Phase 1 results disclosed Monday indicate the company’s protein-degrading drug can affect a tough-to-reach target called ...

Septerna has been working on small-molecule drugs that can target one or multiple of those targets at the same time, according to a recent company presentation, which indicates it has identified a ...

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical ...

We’re back with another hires round-up for digital health companies and pharma suppliers. There was plenty of action across the sector in March. That’s it for this round-up. Remember, if you ...

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...